BCGM Wealth Management’s Pfizer PFE Stock Holding History

BCGM Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	57,029 +2,631	+5%	+$68.8K	0.29%	74
2026 Q1	$1.53M	Buy	54,398 +5,180	+11%	+$138K	0.38%	67
2025 Q4	$1.23M	Buy	+49,218	New	+$1.24M	0.31%	74
2023 Q3	–	Sell	-6,209	Closed	-$228K	–	124
2023 Q2	$228K	Buy	6,209 +286	+5%	+$11.1K	0.1%	112
2023 Q1	$242K	Sell	5,923 -557	-9%	-$24.1K	0.12%	92
2022 Q4	$332K	Buy	6,480 +81	+1%	+$3.88K	0.16%	83
2022 Q3	$301K	Sell	6,399 -194	-3%	-$9.43K	0.15%	84
2022 Q2	$333K	Buy	6,593 +542	+9%	+$27.6K	0.17%	80
2022 Q1	$297K	Buy	6,051 +850	+16%	+$44.1K	0.16%	87
2021 Q4	$307K	Buy	5,201 +3	+0.1%	+$149	0.17%	87
2021 Q3	$227K	Buy	5,198 +405	+8%	+$17.9K	0.13%	92
2021 Q2	$205K	Buy	+4,793	New	+$186K	0.12%	96

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BCGM Wealth Management's PFE Position: Q2 2026 in Review

BCGM Wealth Management increased its Pfizer (PFE) stake by 4.8% in Q2 2026, buying an estimated $68.8K and bringing the position to 57,029 shares worth $1.37M. The position accounts for 0.29% of the portfolio, ranked #74.

BCGM Wealth Management first reported a position in PFE in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.53M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

BCGM Wealth Management held 57,029 shares of Pfizer worth $1.37M as of Q2 2026.
BCGM Wealth Management bought 2,631 Pfizer shares in Q2 2026, an estimated $68.8K.
Pfizer made up 0.29% of BCGM Wealth Management's portfolio in Q2 2026, its #74 holding.
BCGM Wealth Management first reported a position in Pfizer in Q2 2021 and has held it in 12 quarters since.
BCGM Wealth Management's Pfizer position peaked at $1.53M in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BCGM Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.